HeartFlow, Inc. (HTFL)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
25. 37
+1.25
+5.1824%
$
2.19B Market Cap
- P/E Ratio
- Div Yield
1.63M Volume
- Eps
$ 24.12
Previous Close Want to track HTFL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
HTFL closed today higher at $25.37, an increase of 5.1824% from yesterday's close, completing a monthly decrease of -13.5605% or -$3.98. Over the past 12 months, HTFL stock lost -13.5605%.
HTFL is not paying dividends to its shareholders.
The last earnings report, released on Mar 18, 2026, exceeded the consensus estimates by 0.1683%. On average, the company has surpassed earnings expectations by 0.1694%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
HeartFlow: A Premium AI Diagnostics Story
I recommend a buy rating for HeartFlow, Inc. due to its strong clinical workflow integration and expanding product suite. HTFL's AI-enabled platform, anchored by FFRCT and Plaque Analysis, drives adoption, monetization, and workflow efficiency in coronary artery disease diagnosis. Plaque Analysis, validated and soon to have its own billing code, broadens HTFL's addressable market and supports incremental revenue growth from existing CCTA scans.
Seekingalpha | 2 weeks ago
Heartflow Q1 Earnings Call Highlights
Heartflow NASDAQ: HTFL reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its Plaque Analysis product and continued expansion of the coronary CT angiography, or CCTA, market.
Marketbeat | 2 months ago
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
HeartFlow, Inc. (HTFL) Q1 2026 Earnings Call Transcript
Seekingalpha | 2 months ago
HeartFlow, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 538,351 | $15.47M | $13.22M | -$2.25M | -14.53% |
 Joseph Castro Nuveen LLC | 23,239 | $677,417 | $570,749.84 | -$106,667.16 | -15.75% |
| TC Thomas Cagna Sandia Investment Management LP | 15,917 | $497,805.55 | $387,738.12 | -$110,067.43 | -22.11% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 14 | $340.62 | $339.22 | -$1.4 | -0.41% |
 Regan O'Neill Burkehill Global Management LP | 65,000 | $2.19M | $1.6M | -$583,901.5 | -26.69% |
HeartFlow, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Gene Mannheimer Freedom Capital Markets | 2,551.45 | $78,354.98 | $64,628.19 | -$13,726.79 | -17.52% |
HeartFlow, Inc. (HTFL) FAQ
What is the stock price today?
The current price is $25.37.
On which exchange is it traded?
HeartFlow, Inc. is listed on NASDAQ (NMS).
What is its stock symbol?
The ticker symbol is HTFL.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 2.19B.
Has HeartFlow, Inc. ever had a stock split?
No, there has never been a stock split.
HeartFlow, Inc. Profile
| Health Care Technology Industry | Healthcare Sector | John Farquhar CEO | NASDAQ (NMS) Exchange | 42238D107 CUSIP |
| US Country | 843 Employees | - Last Dividend | - Last Split | - IPO Date |
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Contact Information
Address: 331 E. Evelyn Avenue
Phone: 650-241-1221
Website: https://www.heartflow.com
